Efficacy and safety of furmonertinib plus anlotinib as first-line treatment for locally advanced or metastatic NSCLC patients: a single-arm, phase I/II trial
肿瘤科
医学
相(物质)
内科学
临床研究阶段
临床试验
物理
量子力学
作者
Huiyang Shi,Haohua Zhu,Le Tang,Jingyu Lu,Kai Zhu,Mindy Wang,Xingsheng Hu,Yuankai Shi